Related Experiment Videos
Potential hepatotoxicity of lamotrigine
M Fayad1, R Choueiri, M Mikati
1Department of Pediatrics, American University of Beirut Medical Center, Lebanon.
Pediatric Neurology
|February 11, 2000
Summary
Lamotrigine, an antiepileptic drug, can cause reversible liver damage (hepatotoxicity) in children, even leading to hepatic failure in one case. Caution is advised when using lamotrigine in children with complex neurological conditions or on multiple medications.
Area of Science:
- Neurology
- Hepatology
- Pharmacology
Background:
- Lamotrigine is an antiepileptic drug effective for various seizures in pediatric and adult populations.
- Hepatotoxicity is a potential adverse effect associated with antiepileptic drug therapy.
- Previous reports have documented lamotrigine-induced hepatotoxicity, particularly in patients with severe hepatic involvement.
Observation:
- Three pediatric cases of reversible hepatotoxicity during lamotrigine treatment are presented.
- One child experienced severe hepatic failure, which resolved with intensive therapy and drug discontinuation.
- All affected children were on polytherapy, and two had underlying conditions like epilepsia partialis continua secondary to encephalitis.
Findings:
- The temporal association between lamotrigine initiation and liver enzyme normalization upon discontinuation suggests a causal link, though causality remains an assumption due to case complexity.
- Literature review identified six prior cases (five adults, one child) of lamotrigine-associated hepatotoxicity, some with multisystem failure.
- The reported cases highlight a potential risk of hepatotoxicity, especially in vulnerable pediatric patients.
Implications:
- Lamotrigine should be administered with caution in pediatric patients, particularly those on polytherapy or with complex acute neurological conditions.
- Close monitoring of liver function is recommended for children receiving lamotrigine, especially those with conditions such as status epilepticus or encephalitis.
- Further research may be warranted to elucidate the mechanisms and risk factors for lamotrigine-induced hepatotoxicity in specific pediatric populations.